Matches in Nanopublications for { <http://purl.org/np/RAQpp12qzkzqBMsz2q-vYLAf5nTBPkT9aS4OjjAwA-E3U#assertion> ?p ?o ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion wasAttributedTo 0000-0002-3668-2627 provenance.
- assertion generatedAtTime "2022-10-13T13:46:07.779203" provenance.
- assertion wasQuotedFrom " Etesevimab in combination with bamlanivimab is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients, including neonates, with positive results of direct SARS-CoV-2 viral testing. This combination regimen is also used for post-exposure prophylaxis of COVID-2019 in unvaccinated or immunocompromised adults." provenance.